Why the uptake of innovative medicines matters now more than ever

One of Newmarket Strategy managers, Cristina Ruiz de Villa, has written an opinion piece in response to the article published this week by The Association of the British Pharmaceutical Industry (ABPI) and NHS Confederation on the ‘true cost of variation in uptake of innovative medicines’. Read more here.

Previous post
Back to list
Next post